US Broker Ratings

Roivant Sciences Ltd. (ROIV) Investor Outlook: Strong Buy Ratings and 54% Potential Upside

Roivant Sciences Ltd. (ROIV), a prominent player in the biotechnology sector, is garnering significant attention from investors, particularly due to its promising pipeline and strong analyst support. With a market..

Veeva Systems Inc. (VEEV) Stock Analysis: Navigating a 12.74% Upside Potential with Cloud-Based Solutions in Healthcare

Veeva Systems Inc. (NYSE: VEEV), a leader in providing cloud-based software solutions for the life sciences industry, is garnering attention from investors due to its robust market potential and strategic..

Novartis AG (NVS) Stock Analysis: Strong Revenue Growth and Robust Dividend Yield Amidst Mixed Analyst Ratings

Novartis AG (NYSE: NVS), a heavyweight in the healthcare sector, is a Swiss-based pharmaceutical giant renowned for its comprehensive portfolio of medicines. With a market capitalization of $222.69 billion, Novartis..

Royalty Pharma plc (RPRX) Stock Analysis: Unpacking the 28% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) is making waves in the biotechnology sector, capturing the attention of investors with its unique business model and a compelling potential upside of nearly 28%...

Gilead Sciences, Inc. (GILD) Stock Report: Analyzing a 7.14% Potential Upside Amidst Strong Dividend Yield

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a prominent figure in the biopharmaceutical industry, committed to researching and developing treatments for unmet medical needs worldwide. With a current market capitalization..

Encompass Health Corporation (EHC) Stock Analysis: A Strong Buy with 9.41% Potential Upside

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, is making waves with its robust performance and promising outlook. With a market capitalization of $11.98 billion, Encompass..

Doximity, Inc. (DOCS) Stock Analysis: Unpacking a 19.33% Potential Upside in the Healthcare Information Sector

For investors seeking exposure to the healthcare information services sector, Doximity, Inc. (NYSE: DOCS) represents a compelling opportunity. With a market capitalization of $9.58 billion, Doximity stands as a digital..

Genmab A/S (GMAB) Stock Analysis: Exploring a Potential 40% Upside for Biotech Investors

Genmab A/S (GMAB), a prominent player in the biotechnology sector headquartered in Copenhagen, Denmark, is captivating investor interest with a compelling potential upside of 40.86%. As a company specializing in..

The Ensign Group, Inc. (ENSG) Stock Analysis: Healthcare Giant with a 14.98% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a robust player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $8.31 billion, the..

Baxter International Inc. (BAX) Stock Analysis: Navigating Potential 28% Upside Amid Healthcare Sector Dynamics

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, continues to captivate investor interest with its diverse portfolio of medical products and therapies. Despite some recent financial hurdles,..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a Potential 11.93% Upside

Boston Scientific Corporation (NYSE: BSX), a stalwart in the healthcare sector, is gaining the spotlight among investors due to its robust market position and promising growth potential. With a market..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 12% Potential Upside for Investors

AptarGroup, Inc. (NYSE: ATR) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. With a robust market capitalization of $10.3 billion, this U.S.-based company is..

GSK plc (GSK): Analyst Ratings Highlight a 7.59% Upside in the Healthcare Juggernaut

GSK plc (NYSE: GSK) stands as a formidable player in the healthcare sector, with a market capitalization of $78.44 billion. Headquartered in London, GSK’s reach is global, engaging in the..

Align Technology, Inc. (ALGN) Stock Analysis: Unveiling a 33% Potential Upside for Investors

Align Technology, Inc. (NASDAQ: ALGN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, has caught the attention of investors with its potential upside..

Hologic, Inc. (HOLX) Stock Analysis: Navigating the Healthcare Sector with a 23.69% Upside Potential

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, stands out as a compelling investment opportunity with strong analyst endorsement and a significant upside potential of 23.69%. Headquartered..

ResMed Inc. (RMD) Stock Analysis: Navigating a Promising 8.91% Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, continues to pique the interest of investors with its innovative contributions to medical instruments and supplies. Headquartered in San..

Insmed Incorporated (INSM) Stock Analysis: Unpacking a 43% Potential Upside

Insmed Incorporated (NASDAQ: INSM), a biotechnology company headquartered in Bridgewater, New Jersey, is making waves with its promising pipeline of therapies for serious and rare diseases. With a market capitalization..

Investor Outlook: Koninklijke Philips N.V. (PHG) Shows 44.86% Potential Upside Amidst Healthcare Sector Challenges

Koninklijke Philips N.V. (NYSE: PHG), a longstanding leader in the healthcare technology space, is attracting investor attention with its potential upside of 44.86%. As the company navigates a dynamic market..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating a 26.50% Potential Upside Amidst Challenges

Pfizer Inc. (NYSE: PFE) remains a prominent figure in the healthcare sector, boasting a market capitalization of $132.58 billion. The company is renowned for its extensive portfolio of biopharmaceutical products,..

Labcorp Holdings Inc. (LH) Stock Analysis: Strong Buy Ratings and a 12.93% Upside Potential

Labcorp Holdings Inc. (NYSE: LH), a leading player in the healthcare sector, has captured the attention of investors with its robust diagnostics and research capabilities. Headquartered in Burlington, North Carolina,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds